Your browser doesn't support javascript.
loading
Clinical follow-up of 304 patients with multiple sclerosis three years after mitoxantrone treatment.
Debouverie, M; Taillandier, L; Pittion-Vouyovitch, S; Louis, S; Vespignani, H.
Affiliation
  • Debouverie M; Department of Neurology, Central Hospital, 54000 Nancy, France. m.debouverie@chu-nancy.fr
Mult Scler ; 13(5): 626-31, 2007 Jun.
Article in En | MEDLINE | ID: mdl-17548442
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Mitoxantrone / Multiple Sclerosis, Chronic Progressive / Multiple Sclerosis, Relapsing-Remitting / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2007 Document type: Article Affiliation country:
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Mitoxantrone / Multiple Sclerosis, Chronic Progressive / Multiple Sclerosis, Relapsing-Remitting / Antineoplastic Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2007 Document type: Article Affiliation country: